Don’t delay: Register now for INVEST Pop Health
Industry executives will share their insights at the INVEST Pop Health conference, held in collaboration with New Orleans Business Alliance, scheduled for November 15-16.
Push for better patient outcomes drives new standard of care
In this webinar on Feb. 10, healthcare experts from Desert Oasis Healthcare and iRhythm Technologies will discuss how Zio monitors, designed to be worn for longer duration than holter monitors, represent a new standard of care in remote cardiac monitoring.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Silicon Valley startup VivaLNK wants to be the Amazon Cloud of remote patient monitoring
VivaLNK is currently developing a cardiac device, which is the centerpiece of a new platform with the capability to diagnose a-fibrillation more quickly and efficiently than traditional clinical standards.
FDA nod to Apple Watch notable, but …
Apple Watch's entry into the device world garnered a ton of attention and praise, but a good portion of observers have reservations about whether it will truly move the needle in healthcare.
Gilead is using iRhythm patch to test heartbeat irregularities – pharma and wearables unite
Gilead Sciences has started a Phase II/III trial of its novel cardiac patch worn to monitor changes in arrhythmia.
California start-up focusing on arrhythmia diagnostics raises nearly $3.5 million
California arrhythmia diagnostic company iRhythm Technologies has raised nearly $3.5 million, by issuing debt, options and warrants, according to a recent regulatory filing. San Francisco-based iRhythm makes the Zio Patch, a single-use, water-resistant, continuous cardiac rhythm monitoring device that can be worn for up to 14 days. It is meant to be an early diagnostic […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
St. Jude Medical reinvests in iRhythm Technologies
St. Jude Medical’s partnership with a California-based arrhythmia-diagnostic company seems to be going well enough that it recently poured more money into that startup. In May 2010, the Little Canada, Minnesota-based company signed a co-branding and co-marketing relationship with San Francisco-based iRhythm Technologies Inc. and was the lead investor in iRhythm’s $10 million equity round. […]